Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mutational signatures and clonal dynamics in normal human tissues

ABSTRACT: Somatic mutations (burdens and signatures) and clonal dynamics in normal human tissues

PROVIDER: EGAS00001002471 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Mutational signatures

Project description:Mutational signatures

| PRJEB60585 | ENA

Exploring the landscape of somatic mutations in normal tissue GI MAP WGS

Project description:Somatic mutations (burdens and signatures) and clonal dynamics in normal human tissues from the gastrointestinal tract of individuals with tumour predisposition syndromes and DNA damage repair defects.

| EGAS00001004122 | EGA

Exploring the landscape of somatic mutations in normal tissue GI LYNCH WGS

| EGAS00001003882 | EGA

Proteomic signatures in distant normal tissues demonstrate superior predictive value for hepatocellular carcinoma recurrence

Project description:To investigate the molecular signatures associated with hepatocellular carcinoma (HCC) recurrence, we conducted a comprehensive proteomic analysis using clinical samples, including adjacent normal tissues (ANTs), primary tumor tissues (PTTs), and distant normal tissues (DNTs) (n=8 per group). These samples were processed using isobaric tags for relative and absolute quantitation (iTRAQ)-based quantitative proteomics, enabling high-throughput and accurate comparison of protein expression profiles across different tissue types. By systematically analyzing the proteomic differences between ANTs, PTTs, and DNTs, we aimed to identify tissue-specific biomarkers and dysregulated pathways that may contribute to HCC pathogenesis and recurrence. Our findings highlight the unique proteomic signatures of DNTs, which demonstrate superior predictive value for HCC recurrence compared to conventional tumor-centric approaches. This study provides novel insights into the role of distal microenvironmental changes in cancer progression and offers potential biomarkers for improved prognostic assessment.

2025-11-25 | PXD065775 | Pride

Proteomic and Genomic Signatures of Repeat-instability in Cancer and Adjacent Normal Tissues

Project description:Repetitive sequences are hotspots of evolution at multiple levels. However, due to technical difficulties involved in their assembly and analysis, the role of repeats in tumor evolution is poorly understood. We developed a rigorous motif-based methodology to quantify variations in the repeat content of proteomes and genomes, directly from proteomic and genomic raw sequence data, and applied it to analyze a wide range of tumors and normal tissues. We identify high similarity between the repeat-instability in tumors and their patient-matched normal tissues, but also tumor-specific signatures, both in protein expression and in the genome, that strongly correlate with cancer progression and robustly predict the tumorigenic state. In a patient, the hierarchy of genomic repeat instability signatures accurately reconstructs tumor evolution, with primary tumors differentiated from metastases. We find an inverse relationship between repeat-instability and point mutation load, within and across patients, and independently of other somatic aberrations. Thus, repeat-instability is a distinct, transient and compensatory adaptive mechanism in tumor evolution.

2020-06-02 | PXD012574 | Pride

Exploring the landscape of somatic mutations in normal tissue POL WGS

Project description:Somatic mutations (burdens and signatures) and clonal dynamics in individuals with germline DNA polymerase mutations.

| EGAS00001003682 | EGA

Exploring the landscape of somatic mutations in normal tissue POL TGS

Project description:Somatic mutations (burdens and signatures) and clonal dynamics in individuals with germline DNA polymerase mutations.

| EGAS00001003754 | EGA

Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues.

Project description:Mutational signatures' association with replication timing (RT) has been studied in cancer samples, but the RT distribution of somatic mutations in non-cancerous cells was only minimally explored. Here, we performed comprehensive analyses of mutational signatures in 2.9 million somatic mutations across multiple non-cancerous tissues, stratified by early and late RT regions. We found that many mutational processes are active mainly or solely in early RT, such as SBS16 in hepatocytes and SBS88 in the colon, or in late RT, such as SBS4 in lung and hepatocytes, and SBS18 across many tissues. The two ubiquitous signatures, SBS1 and SBS5, showed late and early bias, respectively, across multiple tissues and in mutations representing germ cells. We also performed a direct comparison with cancer samples in 4 matched tissue-cancer types. Unexpectedly, while for most signatures the RT bias was consistent in normal tissue and in cancer, we found that SBS1's late RT bias is lost in cancer.

| S-EPMC10185532 | biostudies-literature

Gene expression signatures for bladder cancer tissues and normal adjacent tissues.

Project description:To identify aberrantly expressed long intergenic noncoding RNAs (lincRNAs) in muscle-invasive bladder cancer tissues compared with normal adjacent tissues, we have employed microarray expression profiling as a discovery platform to identify lincRNAs that may play important roles in bladder cancer progression. Samples of fresh frozen cancer tissues, together with normal adjacent tissues (3 cm away from the tumor), were obtained during surgical resection, and total RNA was extracted for microarray analysis.

2017-12-31 | GSE100926 | GEO

Gene expression signatures for bladder cancer tissues and normal adjacent tissues

Project description:To identify aberrantly expressed long intergenic noncoding RNAs (lincRNAs) in bladder cancer tissues compared with normal adjacent tissues, we have employed microarray expression profiling as a discovery platform to identify lincRNAs that may play important roles in bladder cancer origin and progression. Samples of fresh frozen cancer tissues, together with normal adjacent tissues (3 cm away from the tumor), were obtained during surgical resection, and total RNA was extracted for microarray analysis.

2014-09-22 | GSE61615 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data